Activator Methods International has announced that it has been awarded a Small Business Innovative Research grant by the National Institutes of Health in the amount of $98,786. The title of the funded research project is "Efficacy of Instrument-Assisted Manipulation Determined by an Animal Model," and the project will be conducted over the next 12 months.
The principal investigator named for the project is Arlan W. Fuhr, DC, co-founder and CEO of Activator Methods International, headquartered in Phoenix, Ariz. In addition to the principal investigator, key investigative personnel will include Xue-Jun Song, PhD, and Zhijiang Huang, PhD of Parker College of Chiropractic, which will house the animal subjects and manage primary data acquisition. Analysis and reporting of the data will originate from Activator Methods.
"Receiving this award from NIH further reinforces Activator Methods' position in the research world," said Dr. Fuhr. "Studying the positive impact our adjusting instrument has on inflammation is very exciting, and we are enthusiastic about the promise these results may show for helping human patients who face similar issues."
The study will evaluate the effect of the Activator adjusting instrument in treating vertebrate animal subjects with spinal injury on motor behavior. The research is intended to provide a basis for estimating a more realistic and cost-effective schedule of manipulative intervention on human patients. Further, the investigations will identify, in detail, links between pain and inflammation in order to manage pain by suppression of inflammation. The research will have the potential to identify means to prevent or delay a broad array of chronic diseases or life-threatening conditions with the control of inflammatory processes.
Source: Activator Methods International
